Skip to main content
Funded Studies

Richard Wade-Martins, MA, DPhil

Professor of Molecular Neuroscience at University of Oxford

Location: Oxford United Kingdom

Richard Wade-Martins, MA, DPhil, is a molecular geneticist with extensive and long-standing research programs in molecular mechanisms of neurodegenerative disease, with a focus on Parkinson’s disease working on SNCA, MAPT, LRRK2 and GBA. Previous, highly cited work from his group uncovered the genetic basis of regulation of alternative splicing at the MAPT locus, the role of alpha-synuclein in regulating dopamine release, and a key role for LRRK2 in autophagy. More recently, he has focused on understanding mechanisms of Parkinson’s using cellular phenotyping, phenotypic drug screens and transcriptomic profiling of patient induced pluripotent stem cell (iPSC)-derived dopamine neurons, and characterising highly physiological BAC transgenic models to model Parkinson’s in an age-dependent manner.

Since 2010, he has been founding director of the Oxford Parkinson’s Disease Centre (OPDC; www.opdc.ox.ac.uk), a highly multi-disciplinary study to exploit a depth and breadth of models to provide mechanistic rationale for identifying new drugs and therapeutic targets for Parkinson’s. Further details: https://www.dpag.ox.ac.uk/research/wade-martins-group.


Associated Grants

  • Computer Simulation of LRRK2 and GBA Interactions to Identify Therapeutic Targets for Parkinson's Disease

    2019


  • Ordering the Earliest Neuronal Response Events to Native Alpha-synuclein Exposure

    2018


  • Pre-clinical Development of a Vaccine Against Alpha-synuclein Based on Virus-like Particles

    2013


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.